ARTIVION, INC. Cost of Revenue
ARTIVION, INC. (AORT) reported Cost of Revenue of $15.47 million for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-10-27.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2016-10-27
- ARTIVION, INC. cost of revenue for the quarter ending 2016-09-30 was $15.47M, a 12.75% increase year-over-year.
- ARTIVION, INC. cost of revenue for the quarter ending 2015-09-30 was $13.72M.
| Period end | Cost of Revenue 3 month | Cost of Revenue 9 month |
|---|---|---|
| 2016-09-30 | $15.47M 10-Q · filed 2016-10-27 | $47.65M 10-Q · filed 2016-10-27 |
| 2015-09-30 | $13.72M 10-Q · filed 2016-10-27 | $41.86M 10-Q · filed 2016-10-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |